Literature DB >> 33339353

Tumor Hypoxia and Circulating Tumor Cells.

Walter Tinganelli1, Marco Durante1,2.   

Abstract

Circulating tumor cells (CTCs) are a rare tumor cell subpopulation induced and selected by the tumor microenvironment's extreme conditions. Under hypoxia and starvation, these aggressive and invasive cells are able to invade the lymphatic and circulatory systems. Escaping from the primary tumor, CTCs enter into the bloodstream to form metastatic deposits or re-establish themselves in cancer's primary site. Although radiotherapy is widely used to cure solid malignancies, it can promote metastasis. Radiation can disrupt the primary tumor vasculature, increasing the dissemination of CTCs. Radiation also induces epithelial-mesenchymal transition (EMT) and eliminates suppressive signaling, causing the proliferation of existent, but previously dormant, disseminated tumor cells (DTCs). In this review, we collect the results and evidence underlying the molecular mechanisms of CTCs and DTCs and the effects of radiation and hypoxia in developing these cells.

Entities:  

Keywords:  CTCs; DTCs; EMT; invasion; metastasis; migration

Year:  2020        PMID: 33339353     DOI: 10.3390/ijms21249592

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  3 in total

1.  Dissemination of circulating tumor cells at night: role of sleep or circadian rhythm?

Authors:  Yves Dauvilliers; Frédéric Thomas; Catherine Alix-Panabières
Journal:  Genome Biol       Date:  2022-10-14       Impact factor: 17.906

2.  Dormancy: There and Back Again.

Authors:  E S Pshennikova; A S Voronina
Journal:  Mol Biol       Date:  2022-10-05       Impact factor: 1.540

Review 3.  Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?

Authors:  Giovanni Barillari; Roberto Bei; Vittorio Manzari; Andrea Modesti
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.